期刊文献+

HGF、c-Met鼻内翻性乳头瘤恶变中的表达变化及其意义 被引量:2

Expressions and significances of HGF and c-Met in the malignant transformation of nasal inverted papilloma
下载PDF
导出
摘要 目的:分析肝细胞生长因子(HGF)与其受体(c-Met)在不同期鼻内翻性乳头瘤中的表达变化,探讨其在鼻内翻性乳头瘤恶变中的作用。方法:选择我院2005年1月至2010年12月间确诊为鼻内翻性乳头状瘤的55例及鼻腔恶性乳头状瘤30例作为实验对象,所有患者均行内镜下切除病变组织,对手术切除组织采用免疫组织化学方法SP法检测HGF、c-Met的表达,并统计其染色得分,比较鼻内翻性乳头瘤组织、癌旁组织与恶性组织的HGF、c-Met表达。分析不同分型的鼻内翻性乳头瘤的HGF、c-Met的表达变化。结果:HGF、c-Met在鼻内翻性乳头瘤组织、癌旁组织与恶性组织中的表达变化一致,均为恶性组织高于鼻内翻性乳头瘤组织与癌旁组织,癌旁组织的表达最低。鼻内翻性乳头瘤的T1期HGF表达明显低于T3期(P<0.05),T4期(P<0.01),c-Met表达T1期明显低于T3、T4期(P<0.01)。结论:HGF、c-Met在鼻内翻性乳头瘤中的表达与其不同分期有关,HGF、c-Met可能促进鼻内翻性乳头的恶变。 Objective To analysis the expressions of HGF and c-Met in different stages of intranasal inverted papilloma and try to explore the effects of HGF and c-Met in the malignant transformation of nasal inverted papilloma. Methods 30 cases with confirmed malignant papilloma and 55 cases with nasal inverted papilloma in our hospital from Jan 2005 to Dec 2010 were received as experimental objects. All the patients underwent endoscopic removal of diseased tissue. The expressions of HGF and c-Met in nasal inverted papilloma tissue, adjacent tissues and malignant tissues were determined by immunohistochemical method, and the stain score of each sample was calculated. The expressions of HGF and c-Met in different stages of nasal inverted papilloma were analyzed. Results The staining scores of H(;F and 〈..-Met in malignant tissue were higher than those in nasal inverted papilloma tissues and tile adjacent tissues, the expressions of HGF and c-Met in the adjacent tissues were the minimum. Expressions of HCF and c-Met in T1 stage of inverted papilloma were significantly lower tban those in T3 stage (P 〈 0.05, P 〈 0.01) and T4 stage (both P 〈 0.01). Conclusions The expressions of HGF and c-Met in nasal inverted papilloma were related to its stage, and may contribute to the malignant transtormation of it.
出处 《实用医学杂志》 CAS 北大核心 2012年第24期4085-4087,共3页 The Journal of Practical Medicine
关键词 鼻内翻性乳头瘤 恶变 HGF C-MET Nasal inverted papilloma Malignant Transformation HGF c-Met
  • 相关文献

参考文献8

二级参考文献85

  • 1郑艳,张华,王春利,丁军.基质金属蛋白酶在鼻内翻性乳头状瘤及鼻息肉组织中的表达[J].新疆医科大学学报,2004,27(4):399-400. 被引量:1
  • 2王靖雯,沈朝妍,王伟,程建新.尿激酶型纤溶酶原激活系统与卵巢恶性肿瘤[J].国外医学(妇幼保健分册),2005,16(6):431-434. 被引量:3
  • 3雷志敏,赵怡芳,尚政军.肿瘤血管形成方式及其分子机制[J].国际口腔医学杂志,2006,33(6):466-468. 被引量:7
  • 4张天泽 徐光炜.肿瘤学(第1版)[M].天津:天津科学技术出版社,1996.1554.
  • 5Tamura M,Daikuhara Y.Structure and function of hepatocyte growth factor/scatter factor(HGF/SF)[J].Curr Topics Biochem Res,2000,2:149-159.
  • 6Morimoto A,Tada K,Nakayama Y,et al.Cooperative roles of hepatocyte growth factor and plasminogen activator in tubular morphogenesis by human microvascular endothelial cells[J].Jpn.J Cancer Res,1994,85:53-62.
  • 7Yamamotoa Tj,Maruia T,Akisue T.Coexpression of hepatocyte growth factor and its receptor c-Met correlates with high MIB-1 proliferative index in malignant fibrous histiocytoma[J].Pathology Research and Practice,2004,200:397-402.
  • 8Yonemura Y,Kaji M,Hirono Y.Correlation between overexpression of c-met and the progression of gastric cancer[J].Int J Oncol,1996,8:555-560.
  • 9Wu CW,Chi CW,Su TL,et al.Serum hepatocyte growth factor level associate with gastric cancer progression[J].Anticancer Res,1998,18:3657-3659.
  • 10Offersena BV,Pfeiffer P,Andreasenc P.Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer:Relation to prognosis and angiogenesis[J].Lung Cancer,2007,56:43-50.

共引文献27

同被引文献20

  • 1Tsang J, Lee VH, Kwong DL. Novel therapy for nasopharyngeal carcinoma-Where are we [J]. Oral 0ncol,2014,22(14) : S1368- 8375.
  • 2Knight J R, Allison S J, Milner J. Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activity [J]. Open Biol, 2013,3 ( 11 ) : 130130-130138.
  • 3Chen J, Wei H, Xie B, et al. Endoplasmic reticulum stress contributes to arsenic trioxide-induced apoptosis in drug- sensitive and -resistant leukemia cells [ J ]. Leuk Res, 2012,36 (12) : 1526-1535.
  • 4Reddy CA, Somepalli V, Golakoti T, et al. Mitochondrial- targeted curcuminoids: a strategy to enhance bioavailability and anticancer efficacy of curcumin [J]. PLoS One,2014,9 (3): e89351.
  • 5Cho IR, Koh SS, Malilas W, et al. SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of beta-catenin [J]. Biochem Biophys Res Commun,2012,423 (2) : 270-275.
  • 6Kim YJ, Hwang SH, Lee SY, et al. miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose [ J ]. Stem Cells Dev, 2012,21 (10) : 1749-1760.
  • 7Vaziri H, Dessain SK, Ng EE, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase [J]. Cell,2001,107(2) : 149-159.
  • 8Elangovan S, Ramachandran S, Venkatesan N, et al. SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor alpha in breast cancer [J]. Cancer Res,2011,71 (21):6654- 6664.
  • 9Lee H, Kim KR, Noh SJ, et al. Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma [J]. Hum Pathol, 2011,42 (2) : 204-213.
  • 10Zhao G, Cui J, Zhang JG, et al. SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells [J]. Gene Ther, 2011,18 (9) : 920-928.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部